SN

Stacy Nelson

Vice President, Global Drug Development

Basking Biosciences

Basking Biosciences Pipeline

DrugIndicationPhase
BB-031 / BB-025Acute Thrombotic Conditions (e.g., Acute Ischemic Stroke)Pre-clinical